PT Kalbe Farma Tbk. (KLBF.JK)
IDR 1355.0
(3.04%)
IDR 1355.0
(3.04%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 4432.82 Billion IDR | -11.38% |
| 2022 | 5246.05 Billion IDR | 8.22% |
| 2021 | 4874.45 Billion IDR | 13.4% |
| 2020 | 4354.33 Billion IDR | 7.82% |
| 2019 | 3952.82 Billion IDR | -0.83% |
| 2018 | 3799.02 Billion IDR | 2.68% |
| 2017 | 3726.12 Billion IDR | 4.75% |
| 2016 | 3560.09 Billion IDR | 13.29% |
| 2015 | 2948.22 Billion IDR | -0.85% |
| 2014 | 2995.55 Billion IDR | 11.89% |
| 2013 | 2739.39 Billion IDR | 12.53% |
| 2012 | 2438.62 Billion IDR | 21.79% |
| 2011 | 2217 Billion IDR | 8.43% |
| 2010 | 2006.04 Billion IDR | 21.41% |
| 2009 | 1577.91 Billion IDR | 23.94% |
| 2008 | 1230.06 Billion IDR | 1.24% |
| 2007 | 1215.02 Billion IDR | 4.61% |
| 2006 | 1162.55 Billion IDR | 3.29% |
| 2005 | 1124.48 Billion IDR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1402.95 Billion IDR | 28.66% |
| 2024 Q2 | 1242.49 Billion IDR | -11.23% |
| 2024 Q3 | 937.75 Billion IDR | -37.49% |
| 2023 Q2 | 892.09 Billion IDR | -28.21% |
| 2023 FY | - IDR | -11.38% |
| 2023 Q1 | 1242.58 Billion IDR | -9.11% |
| 2023 Q4 | 1133.51 Billion IDR | 38.6% |
| 2023 Q3 | 817.82 Billion IDR | -8.33% |
| 2022 Q1 | 1185.06 Billion IDR | -6.47% |
| 2022 FY | - IDR | 8.22% |
| 2022 Q4 | 1367.18 Billion IDR | 14.2% |
| 2022 Q3 | 1197.14 Billion IDR | 5.94% |
| 2022 Q2 | 1130.03 Billion IDR | -4.64% |
| 2021 Q4 | 1267.03 Billion IDR | 13.21% |
| 2021 Q3 | 1119.23 Billion IDR | 1.75% |
| 2021 Q1 | 1022.49 Billion IDR | 2.53% |
| 2021 FY | - IDR | 13.4% |
| 2021 Q2 | 1099.98 Billion IDR | 7.58% |
| 2020 Q4 | 997.22 Billion IDR | 3.5% |
| 2020 FY | - IDR | 7.82% |
| 2020 Q1 | 978.26 Billion IDR | 40.88% |
| 2020 Q2 | 1036.93 Billion IDR | 6.0% |
| 2020 Q3 | 963.46 Billion IDR | -7.09% |
| 2019 Q2 | 1041.35 Billion IDR | 12.11% |
| 2019 Q1 | 928.9 Billion IDR | -0.81% |
| 2019 Q4 | 694.39 Billion IDR | -32.11% |
| 2019 Q3 | 1022.79 Billion IDR | -1.78% |
| 2019 FY | - IDR | -0.83% |
| 2018 Q2 | 958.14 Billion IDR | 6.13% |
| 2018 FY | - IDR | 2.68% |
| 2018 Q4 | 936.5 Billion IDR | 1.68% |
| 2018 Q3 | 921.03 Billion IDR | -3.87% |
| 2018 Q1 | 902.79 Billion IDR | -2.84% |
| 2017 Q1 | 875.64 Billion IDR | -0.29% |
| 2017 FY | - IDR | 4.75% |
| 2017 Q4 | 929.16 Billion IDR | 6.26% |
| 2017 Q3 | 874.38 Billion IDR | -7.2% |
| 2017 Q2 | 942.22 Billion IDR | 7.6% |
| 2016 Q3 | 857.3 Billion IDR | -4.43% |
| 2016 FY | - IDR | 13.29% |
| 2016 Q4 | 878.21 Billion IDR | 2.44% |
| 2016 Q2 | 897.03 Billion IDR | 8.77% |
| 2016 Q1 | 824.72 Billion IDR | 7.51% |
| 2015 FY | - IDR | -0.85% |
| 2015 Q1 | 776.2 Billion IDR | -14.17% |
| 2015 Q2 | 802.53 Billion IDR | 3.39% |
| 2015 Q4 | 767.14 Billion IDR | 8.71% |
| 2015 Q3 | 705.7 Billion IDR | -12.07% |
| 2014 Q3 | 708.19 Billion IDR | -5.94% |
| 2014 FY | - IDR | 11.89% |
| 2014 Q1 | 712.12 Billion IDR | -7.66% |
| 2014 Q4 | 904.35 Billion IDR | 27.7% |
| 2014 Q2 | 752.91 Billion IDR | 5.73% |
| 2013 FY | - IDR | 12.53% |
| 2013 Q3 | 649.03 Billion IDR | -7.89% |
| 2013 Q4 | 771.23 Billion IDR | 18.83% |
| 2013 Q2 | 704.6 Billion IDR | 12.62% |
| 2013 Q1 | 625.63 Billion IDR | -19.13% |
| 2012 Q1 | 513.39 Billion IDR | -12.28% |
| 2012 FY | - IDR | 21.79% |
| 2012 Q3 | 520.09 Billion IDR | 0.95% |
| 2012 Q2 | 515.19 Billion IDR | 0.35% |
| 2012 Q4 | 773.66 Billion IDR | 48.75% |
| 2011 Q1 | 413.86 Billion IDR | 0.0% |
| 2011 Q4 | 585.29 Billion IDR | 9.08% |
| 2011 Q3 | 536.57 Billion IDR | 13.84% |
| 2011 Q2 | 471.32 Billion IDR | 13.88% |
| 2011 FY | - IDR | 8.43% |
| 2010 FY | - IDR | 21.41% |
| 2009 FY | - IDR | 23.94% |
| 2008 FY | - IDR | 1.24% |
| 2007 FY | - IDR | 4.61% |
| 2006 FY | - IDR | 3.29% |
| 2005 FY | - IDR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|